secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRESCENT BIOPHARMA, INC. (CBIO)
CIK:        0001253689
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001558370-23-006434
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GlycoMimetics amends lease: reduces footprint by ~12,000 sq ft, extends remaining to Jan 2025
--------------------------------------------------------------------------------

- Lease for ~42,000 sq ft in Rockville, MD amended; ~12,000 sq ft terminates Oct 31, 2023; remaining ~30,000 sq ft extended to Jan 31, 2025.
- Annual base rent on extended portion increases 3% on Nov 1, 2023 and Nov 1, 2024.
- No further right to extend lease term beyond Jan 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1253689/000155837023006434/0001558370-23-006434-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1253689/000155837023006434/glyc-20230419x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-006434

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer